Ticker Scorecard - RARE Basics Company: Ultragenyx Pharmaceutical Inc. IPO Date: January 31, 2014 Sector: Healthcare Industry: Biotech Market Cap: $3.93B Activated in VL: True Average Daily Range Avg Daily Range: $1.63 | 2.53% Avg Daily Range (30 D): $0.97 | 2.24% Avg Daily Range (90 D): $0.84 | 1.82% Institutional Daily Volume Avg Daily Volume: .47M Avg Daily Volume (30 D): .66M Avg Daily Volume (90 D): .65M Trade Size Avg Trade Size (Sh.): 68 Avg Trade Size (Sh.) (30 D): 55 Avg Trade Size (Sh.) (90 D): 55 Institutional Trades Total Inst.Trades: 6,362 Avg Inst. Trade: $2.81M Avg Inst. Trade (30 D): $2.77M Avg Inst. Trade (90 D): $2.91M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.38M Avg Closing Trade (30 D): $4.98M Avg Closing Trade (90 D): $5.7M Avg Closing Volume: 73.94K     News Feb 21, 2025 @ 6:00 PM Cell and Gene Therapies in Rare Disorders Market t... Source: Delveinsight Feb 18, 2025 @ 6:00 PM Mucopolysaccharidosis Market Analysis Across 7MM Ã... Source: Delveinsight Feb 5, 2025 @ 1:00 PM Ultragenyx Announces New Data Demonstrating that T... Source: N/A Jan 17, 2025 @ 9:30 PM Ultragenyx Reports Inducement Grant Under Nasdaq L... Source: N/A Jan 12, 2025 @ 4:05 PM Mereo BioPharma Provides Update on Lead Clinical P... Source: Mereo Biopharma Group Plc Financials   TTM Q3 2024 Q2 2024 Basic EPS $-6.35 $-1.4 $-1.52 Diluted EPS $-6.35 $-1.4 $-1.52 Revenue $ 522.75M $ 139.49M $ 147.03M Gross Profit $ $ $ Net Income / Loss $ -558.99M $ -133.52M $ -131.6M Operating Income / Loss $ -535.74M $ -131.99M $ -116.36M Cost of Revenue $ $ $ Net Cash Flow $ 80.56M $ -331.32M $ 368.54M PE Ratio     Splits Jan 17, 2014:   47:15